To better evaluate the role of the AGEs/sRAGE pathway in ESRD, we firstly evaluated the existence of any potential association between AGEs, FGF-23, inflammation, and increased risk of CVDs in DM CKD-G5D patients. The gene discussed is FGF23; the disease is diabetes mellitus.